Nancy L. Bartlett
ORCID：0000-0001-8470-394X
发表论文 935 篇 · 总被引 48888 次 · h-index 98
代表论文
- NCCN Guidelines® Insights: B-Cell Lymphomas 3.2025 (2025 · Journal of the National Comprehensive Cancer Network · 被引 19)
- Circulating tumor DNA analyses of molecular tumor burden are superior to PET-assessed responses in patients with advanced stage classic Hodgkin lymphoma treated on SWOG S1826 (2025 · Blood · 被引 7)
- Interim and end-of-treatment FDG-PET demonstrate limited ability to predict 3-year progression-free survival with nivolumab-AVD in first-line treatment of advanced stage Hodgkin lymphoma: Imaging sub-analysis of Phase 3 S1826 study (2025 · Blood · 被引 5)
- Precise-HL trial: Personalized reduction of chemotherapy intensity through ctdna evaluation in advanced Hodgkin lymphoma (2025 · Blood · 被引 3)
- Fixed treatment duration mosunetuzumab continues to demonstrate clinically meaningful outcomes in patients with relapsed/refractory (R/R) follicular lymphoma (FL) after ≥2 prior therapies: 5-year follow-up of a pivotal Phase II study (2025 · Blood · 被引 3)
- Brentuximab vedotin and nivolumab in combination with chemotherapy for nonbulky, early-stage classical Hodgkin lymphoma (2025 · Blood · 被引 2)